Aaron Ondrey Mirati Therapeutics, Inc. (MRTX) insider trading activity

MRTX Quotes by TradingView

Aaron Ondrey is Chief Financial Officer of Mirati Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2024, when has been sold 39,461 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Aaron Ondrey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2024
SELL
Sale (or disposition) back to the issuer
-
39,461 Reduced 100.0%
0 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$999,983 $58.75 p/Share
17,021 Added 30.14%
39,461 Common Stock
Sep 08 2023
BUY
Grant, award, or other acquisition
$299,971 $35.66 p/Share
8,412 Added 27.27%
22,440 Common Stock

Also insider at

RCKT
ROCKET PHARMACEUTICALS, INC. Healthcare
Chief Financial Officer
AO

Aaron Ondrey

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRTX